Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Biohaven Stock Crushed it on Monday

TheMotleyFool 
0 0 14.04.26
Why Biohaven Stock Crushed it on MondayPhoto, wide shot, wide-angle lens, Bank, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/094456a7-d529-4ef2-b536-c031f2afd618.png
 

Biohaven (NYSE: BHVN) stock got quite the shot in the arm as the trading week began. On Monday, an analyst initiated coverage of the clinical-stage biotech with a very bullish buy recommendation; not suprisingly, investors took this to heart and pushed the price of the shares up by more than 10% that trading session.

The person behind the initiation was Canaccord Genuity's Sumant Kulkami, who flagged Biohaven as a buy with a price target of $21 per share. That figure is significant, as it's more than double Biohaven's present level, even after the Monday price pop.

Image source: Getty Images.

Continue reading


Source Fool.com

Canaccord Financial Inc. Stock

?
-1.160%
We can see a decrease in the price for Canaccord Financial Inc.. Compared to yesterday it has lost -€0.100 (-1.160%).

Show more
Like: 0
BHVN
Share

Comments

Not a member yet? Sign up for free!